Information
-
Trademark
-
98814620
-
International Classifications
-
Filing Date
October 22, 2024
a year ago
-
Transaction Date
July 11, 2025
4 months ago
-
Status Date
June 03, 2025
5 months ago
-
Published for Opposition Date
June 03, 2025
5 months ago
-
Location Date
May 14, 2025
6 months ago
-
Status Code
686
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
QUEEN, ESTHER
-
Attorney Docket Number
140679600756
Attorney Name
Kristen Ruisi
Law Office Assigned Location Code
M20
-
Owners
Mark Drawing Code
4
Mark Identification
BEONE MEDICINES
Case File Statements
- GS0401: Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
- GS0051: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
- PM0001: BE ONE MEDICINES
- GS0441: Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice
- DS0000: "MEDICINES"
- GS0421: Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; scientific research in the nature of conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
Case File Event Statements
-
10/22/2024 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
3/30/2025 - 7 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
3/30/2025 - 7 months ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/30/2025 - 7 months ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/30/2025 - 7 months ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
3/30/2025 - 7 months ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
4/3/2025 - 7 months ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/3/2025 - 7 months ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
4/3/2025 - 7 months ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
5/4/2025 - 6 months ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/28/2025 - 5 months ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
7/9/2025 - 4 months ago
14 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Type: ASCK
-
7/10/2025 - 4 months ago
15 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
6/3/2025 - 5 months ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/3/2025 - 5 months ago
12 - PUBLISHED FOR OPPOSITION
Type: PUBO